Skip to content
10-Q

Quarterly Report

Bio-En Holdings Corp.

0001104659-19-063685

← back to feed
Filed
Nov 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 14, 2019 77.35M sh
Cash And Equivalents Q3 2019 · Sep 30, 2019 $4.69K
Cash And Equivalents Q3 2019 · Dec 31, 2018 $5.42K
Cash And Equivalents Q3 2019 · Sep 30, 2018 $19.01K
Cash And Equivalents Q3 2019 · Dec 31, 2017 $60
Stockholders Equity Q3 2019 · Sep 30, 2019 −$138.88K
Stockholders Equity Q3 2019 · Dec 31, 2018 −$61.58K
Current Liabilities Q3 2019 · Sep 30, 2019 $149.28K
Current Liabilities Q3 2019 · Dec 31, 2018 $73.22K
Total Liabilities Q3 2019 · Sep 30, 2019 $149.28K
Total Liabilities Q3 2019 · Dec 31, 2018 $73.22K
Current Assets Q3 2019 · Sep 30, 2019 $10.4K
Current Assets Q3 2019 · Dec 31, 2018 $11.64K
Total Assets Q3 2019 · Sep 30, 2019 $10.4K
Total Assets Q3 2019 · Dec 31, 2018 $11.64K
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$217.3K
Net Income Q3 2019 · Sep 30, 2018 −$13.4K
Net Income Q3 2019 · Sep 30, 2018 −$49.41K
Operating Income Q3 2019 · Sep 30, 2018 −$13.4K
Operating Income restated Q3 2019 · Sep 30, 2018 −$49.41K